Chitogel is a global medical device company that offers edge wound healing gel for use in endoscopic sinus surgery.
Chitogel has raised $6.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2024.
Chitogel's investors include LCO Capital.
Chitogel is headquartered in Wellington, New Zealand.
Chitogel is a global medical device company that offers edge wound healing gel for use in endoscopic sinus surgery.
Chitogel is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Chitogel — Funding & Investors." VCBacked, October 7, 2024, https://www.vcbacked.co/company/chitogel. Accessed August 16, 2026.
VCBacked. (2024). Chitogel — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/chitogel
{{cite web |title=Chitogel — Funding & Investors |url=https://www.vcbacked.co/company/chitogel |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated